Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.41 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.39 |
| ▸ | MLNR | O43193 | 1/20 | 0.38 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17201467 | 0.91 | ALK (0.43) | PDK2ALKTP53TDP1ALDH1A1 | |
| SCHEMBL28426241 | 0.89 | MLNR (0.38) | PDK2ALKMLNRNR1I2CHRM2 | |
| SCHEMBL2602496 | 0.83 | PDK2 (0.37) | PDK2ALKMLNRNR1I2CHRM2 | |
| SCHEMBL10052204 | 0.83 | PDK2 (0.41) | PDK2ALK | |
| SCHEMBL3557265 | 0.82 | PDK2 (0.41) | PDK2MLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL14427937 | 0.82 | ALK (0.41) | ALKTP53TDP1ALDH1A1TSHR | |
| SCHEMBL12925457 | 0.81 | PDK2 (0.36) | PDK2MLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL2602462 | 0.81 | PDK2 (0.39) | PDK2MLNRNR1I2CHRM2ADRB1 | |
| SCHEMBL24742475 | 0.81 | PDK2 (0.40) | PDK2ALKHTR2AHTR2CTP53 | |
| SCHEMBL14913959 | 0.81 | PDK2 (0.32) | PDK2ALKMLNRNR1I2CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103804658-A | Polymerizable polyfluorene macromonomer and synthesis method thereof | UNIV ZHEJIANG | 2014-05-21 | — | — | CN | disclosed |
| US-7914907-B2 | Light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2011-03-29 | — | — | US | disclosed |
| US-7663301-B2 | for use as robust red organic phosphors | GENERAL ELECTRIC COMPANY (US) | 2010-02-16 | — | — | US | disclosed |
| US-20070184302-A1 | Light-emitting device | CANON KABUSHIKI KAISHA (JP) | 2007-08-09 | — | — | US | disclosed |
| EP-1787338-A1 | LIGHT-EMITTING DEVICE | Canon Kabushiki Kaisha (JP) | 2007-05-23 | — | — | EP | disclosed |
| WO-2006076247-A2 | PHOSPHORESCENT FLUORENE, ANTHRACENE AND/OR THIOPHENE SUBSTITUTED METALLO- PORPHYRINS AND RELATED COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060152149-A1 | Porphyrin compositions | GENERAL ELECTRIC COMPANY (US) | 2006-07-13 | — | — | US | disclosed |
| WO-2006035640-A1 | LIGHT-EMITTING DEVICE | CANON KABUSHIKI KAISHA (JP) | 2006-04-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060152149-A1 | Porphyrin compositions | ACP1, MMS19, MVD | PDK2 1743/4885ALK 1511/4885MLNR 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.